Reshef, Yakir A.
Rumker, Laurie
Kang, Joyce B.
Nathan, Aparna
Korsunsky, Ilya
Asgari, Samira https://orcid.org/0000-0002-2347-8985
Murray, Megan B.
Moody, D. Branch
Raychaudhuri, Soumya https://orcid.org/0000-0002-1901-8265
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (5T32HG2295-17)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007753)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2ELP3_172101)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P400PB_183823)
Foundation for the National Institutes of Health (T32HG010464)
Foundation for the National Institutes of Health (U19 AI111224)
Foundation for the National Institutes of Health (U01 HG009379)
Foundation for the National Institutes of Health (1R01AR063759)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI049313)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19 AI111224)
Article History
Received: 18 April 2021
Accepted: 18 August 2021
First Online: 21 October 2021
Competing interests
: S.R. serves as a consultant for Gilead, Pfizer, Janssen and Rheos Medicines and is a founder of Mestag Therapeutics. I.K. serves as a consultant for Mestag Therapeutics. The other authors declare no competing interests.